PD Dr. Andreas Kremer

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Biochemie und Molekulare Pathobiologie

Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease models (2025) Al Hamwi G, Alnouri MW, Verdonck S, Leonczak P, Chaki S, Frischbutter S, Kolkhir P, et al. Journal article MRGPRX2 ligandome: Molecular simulations reveal three categories of ligand-receptor interactions (2025) Maier P, Macht M, Beck S, Kolkhir P, Babina M, Kremer A, Zahn D, Wolf K Journal article Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. (2025) Roth D, Düll M, Horst LJ, Lindemann A, Malzer X, Koop K, Zundler S, et al. Journal article Sub-optimale Behandlung von Patienten mit Primär Biliärer Cholangitis (PBC) im klinischen Alltag der deutschen PBC Kohorte Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort (2024) Wiegand J, Franke A, Müller T, Stein K, Bantel H, Günther R, Denk G, et al. Journal article OMW: Diagnostik bei Pruritus auf primär unveränderter Haut (2024) Düll M, Kremer A Journal article Gut Pathobiont–Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis–Associated Inflammatory Bowel Disease (2024) Dorner H, Stolzer I, Mattner J, Kaminski S, Leistl S, Edrich LM, Schwendner R, et al. Journal article Empfohlene Diagnostik bei Pruritus auf primär unveränderter Haut (2024) Düll M, Kremer A Journal article Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates (2023) Payani E, Koliogiannis D, Schoenberg MB, Koch D, Eser-Valeri D, Denk G, Rehm M, et al. Journal article Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus (2023) Levy C, Kendrick S, Bowlus CL, Tanaka A, Jones D, Kremer A, Mayo MJ, et al. Journal article